Mirum Pharmaceuticals (MIRM) Net Margin (2021 - 2026)
Mirum Pharmaceuticals' quarterly Net Margin came in at 494.21% in Q1 2026, down 48106.0% year-on-year from N/an in Q1 2025, and down 12745.36% quarter-over-quarter from 3.85% in Q4 2025.
Mirum Pharmaceuticals has reported Net Margin for 6 years, with the latest figure at 494.21% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 48106.0% year-over-year to 494.21%; the trailing twelve-month figure through Mar 2026 stood at 140.24% (down 11985.0% YoY), and the FY2025 full-year result was 4.48%, up 2162.0% from the prior year.
- Net Margin for Q1 2026 stood at 494.21%, down from 3.85% in the prior quarter.
- The five-year high for Net Margin was 2.18% in Q3 2025, with the low at 494.21% in Q1 2026.
- Average Net Margin over 5 years is 104.39%, with a median of 49.42% recorded in 2023.
- Peak annual rise in Net Margin reached 75203 bps in 2022, while the deepest fall reached 196439 bps in 2022.
- Tracing MIRM's Net Margin over 5 years: stood at 130.55% in 2022, then soared by 61 bps to 51.27% in 2023, then jumped by 53 bps to 23.93% in 2024, then surged by 84 bps to 3.85% in 2025, then sank by 12745 bps to 494.21% in 2026.
- The last three Net Margin figures came in at 494.21% (Q1 2026), 3.85% (Q4 2025), and 2.18% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.65% |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -494.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -494.21% |
| Dec 31, 2025 | -3.85% |
| Sep 30, 2025 | 2.18% |
| Jun 30, 2025 | -4.59% |
| Mar 31, 2025 | -13.15% |
| Dec 31, 2024 | -23.93% |
| Sep 30, 2024 | -15.75% |
| Jun 30, 2024 | -31.64% |
| Mar 31, 2024 | -36.52% |
| Dec 31, 2023 | -51.27% |
| Sep 30, 2023 | -49.42% |
| Jun 30, 2023 | -197.45% |
| Mar 31, 2023 | -95.35% |
| Dec 31, 2022 | -130.55% |
| Sep 30, 2022 | -190.13% |
| Jun 30, 2022 | -155.12% |
| Mar 31, 2022 | -283.94% |
| Dec 31, 2021 | 1,833.84% |
| Sep 30, 2021 | -942.16% |
| Jun 30, 2021 | -399.04% |